Global Dysphagia Market – Industry Trends and Forecast to 2029

Análise e dimensão do mercado

Nos últimos anos, prevê-se que o mercado da disfagia prolifere durante o período de previsão. De acordo com a Associação Mundial do Coração, a taxa de incidência global de AVC é de 15 milhões, sendo que 6 milhões de pessoas morrem e outros 6 milhões ficam incapacitados, resultando em perda de visão e dificuldade de fala. Como resultado, a crescente prevalência de disfagia relacionada com o AVC e de problemas faríngeos e laríngeos associados está a impulsionar o mercado da disfagia. Os acidentes cerebrovasculares (AVC) são causados ​​por um fornecimento insuficiente de sangue (oxigénio e nutrientes) ao cérebro.

A Data Bridge Market Research analisa que o mercado da disfagia foi avaliado em 3,05 mil milhões de dólares em 2021 e deverá atingir os 4,62 mil milhões de dólares até 2029, registando um CAGR de 5,30% durante o período de previsão de 2022 a 2029. O relatório de mercado com curadoria da Data A equipa da Bridge Market Research inclui análise especializada aprofundada, epidemiologia dos doentes, análise de pipeline, análise de preços e estrutura regulamentar.

Definição de mercado

A disfagia é uma condição na qual as pessoas têm dificuldade em engolir os alimentos. A capacidade de engolir em segurança é fundamental para uma nutrição e hidratação adequadas, bem como para evitar que os alimentos entrem nos pulmões. Engolir é um ato complicado que requer atividade muscular coordenada em três fases básicas: fase oral (boca), fase faríngea (garganta) e fase esofágica (tubo alimentar). A disfagia é uma condição que ocorre quando um ou mais destes estágios são interrompidos. Os produtos modificadores da textura dos alimentos e outros produtos, como os tubos, são utilizados para auxiliar no processo de deglutição na gestão da disfagia.

Âmbito do relatório e segmentação de mercado

Dinâmica do mercado da disfagia

Motoristas

• Crescente número de pessoas viciadas em fumar

Prevê-se que o número crescente de pessoas viciadas em fumar influencie o crescimento do mercado da disfagia durante o período de previsão. Um dos efeitos adversos mais graves de fumar durante um longo período de tempo é a disfagia. Embora o consumo de tabaco mate aproximadamente 6 milhões de pessoas todos os anos, a crescente prevalência do cancro orofaríngeo está progressivamente a alimentar a expansão do mercado da disfagia.

• Aumentar o investimento em infraestruturas de saúde

Outro fator significativo que influencia a taxa de crescimento do mercado da disfagia é o aumento dos gastos em saúde que ajuda a melhorar as suas infraestruturas.

Além disso, as crescentes iniciativas de organizações públicas e privadas para difundir a sensibilização irão expandir o mercado da disfagia. Além disso, o elevado rendimento disponível e a crescente procura de gestão da disfagia nos serviços de saúde e nas instalações médicas irão expandir o mercado da disfagia. Juntamente com isto, o aumento da população geriátrica e a mudança contínua do estilo de vida aumentarão a taxa de crescimento do mercado.

Oportunidades

• Aumento do número de atividades de investigação e desenvolvimento       

Além disso, o crescimento do mercado é alimentado por um aumento do número de atividades de investigação e desenvolvimento. Isto proporcionará oportunidades benéficas para o crescimento do mercado da disfagia.

Além disso, o crescente foco dos participantes do mercado no lançamento de medicamentos OTC para tratar a disfagia e o aumento do número de mercados emergentes proporcionarão ainda mais oportunidades benéficas para o crescimento do mercado da disfagia durante o período de previsão.

Restrições/Desafios

• Dificuldade no diagnóstico da disfagia

However, difficulty in the diagnosis of exact cause of dysphagia is anticipated to obstruct the market's growth rate. A variety of factors can cause dysphagia, and determining the cause can be challenging in some circumstances.

On the other hand, the high cost associated with the treatment will obstruct the growth rate of market. The dearth of awareness among people and lack of healthcare infrastructure in developing economies will challenge the dysphagia market. Additionally, a decline in clinical visits due to COVID-19 outbreak and lack of advanced therapies for dysphagia will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This dysphagia market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dysphagia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

In the United States, around 15 million people suffer from dysphagia. Dysphagia affects about 1 in every 25 persons throughout their lives.

Dysphagia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Dysphagia Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for a variety of reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of dysphagia in recent months.

Recent Development

• In September 2020, Thick-It Brand announced the launch of a variety pack of dysphagia nutrition products. Purée Protein, Purée Vegetable, and Ready-to-Drink are all available in the new packets. The ready-to-drink alternatives are available in IDDSI Level 2 – Mildly Thick (nectar) and IDDSI Level 3 – Moderately Thick (honey) consistencies and feature the newly reformulated Thick-It Clear Advantage drinks. Purées can be found in IDDSI Level 4 – Puree.

Global Dysphagia Market Scope

The dysphagia market is segmented on the basis of type, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Esophageal Dysphagia
• Oral Dysphagia
• Pharyngeal Dysphagia

Treatment

• Medicines
• Surgery

Route of Administration

• Oral
• Parenteral
• Others

Diagnosis

• Manometry
• Endoscopy
• Barium Swallow Test
• Swallow Study
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Dysphagia Market Regional Analysis/Insights

The dysphagia market is analysed and market size insights and trends are provided by country, type, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.

The countries covered in the dysphagia market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the dysphagia market because of the growing prevalence of dysphagia and presence of refined healthcare expenditure in this region. Additionally, growing focus of major key players on novel technology is projected to propel the market's growth rate in this region.

Asia-Pacific is expected to grow during the forecast period due to the increasing number of generic manufacturers and rising healthcare expenditure in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Dysphagia Market Share Analysis

The dysphagia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dysphagia market.

Some of the major players operating in the dysphagia market are:

• Dr. Reddy's Laboratories Ltd. (India)
• AstraZeneca (UK)
• Johnson & Johnson Private Limited (US)
• Abbott (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Novartis AG (Switzerland)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Dr. Reddy's Laboratories Ltd. (India)
• Cipla Inc. (US)
• Zydus Cadila (India)
• WOCKHARDT (India)
• Lannett (US)
• Cook (US)
• Fresenius Kabi AG (Germany)
• BD (US), Eisai Co., Ltd. (Japan)

SKU-53414